Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

25.06 -0.73 (-2.83%)

Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Is Pfizer Stock a Buy After This $10 Billion Acquisition? ↗

Today 5:45 EST

The company has been on an acquisition spree for years, and this one may be the most important yet.

Via The Motley Fool

Topics Intellectual Property Lawsuit

Healthcare Sector Navigates Mixed Market Close: A Beacon of Stability Amidst Uncertainty

November 14, 2025

As the broader market concluded with a mixed performance on November 14, 2025, the S&P 500 Healthcare sector once again underscored its often-defensive nature, demonstrating resilience amidst an...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Deal Dispatch: Warner Bros., Bill.com, C3 AI—Key Auctions And Buyouts Shake The Market ↗

November 14, 2025

Paramount, Comcast, Netflix, Clearlake, Blackstone, and others drive major M&A activity. On the sell side are WBD, Bill.com and TuneIn.

Via Benzinga

Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks ↗

November 14, 2025

While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate.

Via Benzinga

Topics Artificial Intelligence

AI Revolutionizes Drug Shelf-Life: Optimized Stability Models Promise Safer, More Effective Medicines

November 14, 2025

The pharmaceutical industry is on the cusp of a profound transformation, driven by the integration of data science and Artificial Intelligence (AI) into drug formulation stability models. This...

Via TokenRing AI

Topics Artificial Intelligence Economy Product Recall

AI Revolutionizes Medicine: Precision Bioanalysis and Targeted Delivery Usher in a New Era of Healthcare

November 14, 2025

The convergence of artificial intelligence (AI) with advanced bioanalysis and targeted drug delivery technologies is fundamentally reshaping the landscape of medicine and healthcare. These synergistic...

Via TokenRing AI

Topics Artificial Intelligence

What's going on in today's session: S&P500 most active stocks ↗

November 14, 2025

Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Friday and discover the stocks that are dominating the trading activity and setting the pace for...

Via Chartmill

Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025

November 14, 2025

The pharmaceutical and biotechnology sectors are experiencing a period of significant dynamism and robust growth as of November 2025, fueled by a confluence of scientific advancements, a resurgence in...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Eli Lilly Strikes Deal With Trump: Why Shares Are Up 10% Since ↗

November 14, 2025

Via MarketBeat

Why Pfizer (PFE) Shares Are Sliding Today

November 14, 2025

Shares of global pharmaceutical company Pfizer (NYSE:PFE) fell 2.5% in the morning session after the company cut its stake in its pandemic partner BioNTech by more than half, a move that overshadowed...

Via StockStory

Topics Artificial Intelligence Stocks Supply Chain

Ozempic Maker Novo Nordisk Faces Board Shakeup ↗

November 14, 2025

Novo Nordisk faces board changes, investor friction and bold M&A moves as leadership pushes to regain momentum in the obesity drug market.

Via Benzinga

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields ↗

November 14, 2025

Via Benzinga

Novo Nordisk Stock Falls Premarket As Investors Brace For Contentious Vote To Reinstate Former CEO ↗

November 14, 2025

The board overhaul follows mass resignations triggered by internal disputes over Novo’s direction.

Via Stocktwits

Pfizer Stock Slips Premarket Despite Completing Metsera Deal; Investors React To BioNTech Stake Cut ↗

November 14, 2025

The Metsera buyout brings multiple obesity and cardiometabolic drug candidates into Pfizer’s pipeline, including a GLP-1 nearing Phase 3.

Via Stocktwits

Topics Intellectual Property

Cidara Therapeutics Stock Soars 42% After-Hours On Merck Buyout Buzz — Retail Traders Eye A Potential Blowout Premium ↗

November 13, 2025

Via Stocktwits

AI Revolutionizes Cardiovascular Clinical Trials: A Leap Towards Cheaper, Faster Drug Development

November 13, 2025

San Francisco, CA – November 13, 2025 – Artificial Intelligence (AI) has achieved a pivotal breakthrough in the medical field, successfully adjudicating clinical events in cardiovascular trials. This...

Via TokenRing AI

Topics Artificial Intelligence

Post-Shutdown Jitters: Markets Reel as Government Reopens

November 13, 2025

The United States government, after an unprecedented 43-day shutdown, officially reopened on Thursday, November 13, 2025, as President Donald Trump signed a funding bill into law. While the resolution...

Via MarketMinute

Topics Bonds Economy Government

Gilead’s Experimental One Pill Regimen Proved Non-Inferior To Multi-Pill Regimens In Treating HIV ↗

November 13, 2025

The company now plans to submit the data from the study to regulatory authorities.

Via Stocktwits

Explore the S&P500 index on Thursday and find out which stocks are the most active in today's session. ↗

November 13, 2025

Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.

Via Chartmill

Pfizer CEO Sees Metsera’s Drugs Hit Market As Early As 2028 After Completing Acquisition: Report ↗

November 13, 2025

CEO Albert Bourla told Yahoo Finance that the acquisition of GLP-1 maker Metsera is part of the company's "right to win" in the obesity drug game.

Via Stocktwits

Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run ↗

November 13, 2025

Pfizer plans to sell its remaining BioNTech stake through a $508 million block trade, ending a profitable Covid-19 vaccine partnership.

Via Benzinga

BioNTech Says Collaboration With Pfizer Going Strong After Report Indicated US Pharma Giant Considering Stake Sale In The German Company ↗

November 13, 2025

A BioNTech spokesperson told Reuters that the two companies continue to have a “close and strong collaboration.”

Via Stocktwits

Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead? ↗

November 13, 2025

Pfizer has a huge dividend yield and a high payout ratio compared to Merck, which could make Merck the more attractive dividend stock.

Via The Motley Fool

Topics Intellectual Property

Viking Therapeutics Stock Soars To 10-Month High After Canaccord Boost – Retail Traders See It As Next Big Obesity Play ↗

November 13, 2025

Canaccord said Viking’s obesity pipeline is worth far more than the current valuation.

Via Stocktwits

Reflecting On Generic Pharmaceuticals Stocks’ Q3 Earnings: Viatris (NASDAQ:VTRS)

November 12, 2025

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Viatris (NASDAQ:VTRS) and its peers.

Via StockStory

Topics Artificial Intelligence Intellectual Property

3 Healthcare Stocks Topping a 2025 List of Dividend Yields ↗

November 12, 2025

Turn health into wealth with these three high-yielding dividend stocks.

Via The Motley Fool

Curious about the most active S&P500 stocks in today's session? ↗

November 12, 2025

Let's have a look at what is happening on the US markets on Wednesday. Below you can find the most active S&P500 stocks in today's session.

Via Chartmill

Dow Soars to New Record High as Government Shutdown Nears End

November 12, 2025

New York, NY – November 12, 2025 – The Dow Jones Industrial Average (DJIA) surged by nearly 400 points today, hitting an unprecedented record high, as investors enthusiastically embraced the impending...

Via MarketMinute

Topics Economy Government Stocks

Looking Into Pfizer Inc's Recent Short Interest ↗

November 12, 2025

Via Benzinga

Eledon Pharmaceuticals Stock Plunges Following $50 Million Public Offering

November 12, 2025

Irvine, CA – November 12, 2025 – Eledon Pharmaceuticals (NASDAQ: ELDN) witnessed a significant decline in its stock value today, plummeting by 17.8% in premarket trading. This sharp drop comes on the...

Via MarketMinute

Topics Initial Public Offering Intellectual Property Regulatory Compliance

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.